Approval · Notice of Compliance 243 · 2002
KINERET: Notice of Compliance 243
Issued May 24, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 243
- Date
- May 24, 2002
- Company
- Amgen Canada IncMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Immunomodulatory agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| KINERET | 02245913 | Marketed |
Medicinal ingredients
- ANAKINRA 150 MG per ML